MK-677 warnings on TikTok: what the science actually says

What did @jackwannabejacked actually say?

The creator's core argument is that MK-677 is dangerous because it stimulates growth hormone, and growth hormone causes "rapid growth of cells" — which, in his framing, could feed cancer. He also warns that MK-677 produces something "like insulin" that could cause insulin resistance. His conclusion: avoid it entirely, especially if you're a teenager, because it's "not approved for human consumption" and won't actually build muscle anyway.

He ties this to a stat — "the likelihood of developing cancer in Australia by the age of 85 is 43%" — to frame the cancer risk as especially alarming. He doesn't cite any studies. He positions himself as someone who "studies human physiology," which is doing a lot of work in this video.

Does the science back this up?

Partially, but the logic has real gaps. The claim that growth hormone stimulates cell growth is accurate. The leap from there to "MK-677 causes cancer" is not supported by current clinical evidence, and conflates a plausible biological mechanism with a demonstrated causal outcome.

MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates pituitary release of growth hormone and IGF-1. IGF-1 is the actual mediator of most growth effects. There is legitimate scientific concern about IGF-1 and cancer promotion — specifically that elevated IGF-1 may accelerate proliferation in pre-existing tumors rather than initiating cancer de novo. A 2012 meta-analysis by Rowlands et al. in PLOS ONE found associations between higher circulating IGF-1 and increased risk of breast, prostate, and colorectal cancers. That's worth knowing. But "growth hormone causes rapid cell growth, cancer loves to grow, therefore MK-677 causes cancer" is not how mechanism-to-outcome reasoning works in pharmacology.

On insulin resistance: this is actually the better-supported concern. Clinical trials of MK-677 have documented increased fasting glucose and reduced insulin sensitivity. Nass et al. (2008, Annals of Internal Medicine) noted meaningful increases in fasting blood glucose in older adults taking MK-677 over 12 months. The creator's framing is imprecise but the underlying warning is legitimate.

What did they get wrong (or right)?

The insulin resistance warning is mostly right, though loosely explained. The cancer claim is where the argument falls apart. Saying cancer "loves to grow" and growth hormone causes growth does not constitute evidence that MK-677 causes cancer in healthy people. That's a biological plausibility argument, not clinical evidence, and presenting it as a straightforward risk misleads viewers.

He also says MK-677 is "not approved for human consumption." This is accurate — it has no FDA approval and is not approved by the TGA in Australia either. It has been studied in clinical trials in humans, so "not approved" is the correct framing, but calling it untested in humans would be wrong.

His claim that "you're not going to put on copious amounts of muscle" is fair. Studies like the one by Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) show modest lean mass changes, not dramatic hypertrophy. The muscle-building hype around MK-677 is largely gym-bro mythology.

What he got genuinely right: the warning to teenagers is sound. Adolescents with active growth plates face different risks from hormonal compounds than adults, and there is no clinical justification for teenage use.

What should you actually know?

MK-677 is not a safe supplement hiding behind a scary TikTok. It is an unapproved compound with real documented side effects, including water retention, increased appetite, elevated fasting glucose, and potential impacts on insulin sensitivity. These effects are dose-dependent and have been observed in controlled trials, not just case reports.

The cancer connection is the part to hold loosely. IGF-1 elevation is a documented effect of MK-677 use, and elevated IGF-1 is associated with increased cancer risk in epidemiological studies. But "associated with" is not the same as "causes," and no clinical trial has demonstrated that MK-677 use initiates cancer in previously healthy individuals. If you have a personal or family history of hormone-sensitive cancers, this is an especially relevant conversation to have with a physician, not a TikTok comment section.

The approval status matters. Compounds without regulatory approval have not completed the safety and efficacy review required to establish a known risk profile in general populations. That's a real reason for caution, separate from any specific cancer or insulin claim.